Featuring the growing traction of Registered Reports, an investigation into the inconsistent role of a peer reviewer, unusual citation patterns in some manuscripts and a new Plan S toolkit
Blog
Weekly digest: what’s happening in open science?
Featuring the pros and cons of ‘patient-orientated research’, a new addition to the Medical Publishing and Insights Practices (MPIP) open access toolkit and an update on Plan S.
Weekly digest: what’s happening in open science?
Featuring concerns over financing ‘pay to publish’ models, a fresh demand for clinical trial transparency sanctions, and how one highly cited article may influence a journal’s impact factor and a researcher’s career progression.
Weekly digest: what’s happening in open science?
Featuring the growing need for communication during each stage of the research process, the role of patient experts in a healthcare setting, the association of medical writing support with the quality of clinical trial reporting, and the replacement of supplementary material with online repositories.
Open Pharma top holiday reads
Finding a good book to read on holiday may sometimes be a challenge. Luckily, the Open Pharma team is here to help with its shortlist of the best reads for summer 2019!
Weekly digest: what’s happening in open science?
Featuring a patient’s perspective on the Health Research Authority’s transparency consultation, the launch of the Journal of Trial and Error and the call for ResearchGate to educate users on responsible content sharing.
Weekly digest: what’s happening in open science?
Featuring the use of ‘spin’ in clinical trial abstracts, the first publication in UCL Open: Environment, a new clinical trial educational resource and insights from the OASPA webinar on learned societies and open access.
Open science is essential for medical research, says ABPI
The Association of the British Pharmaceutical Industry (ABPI) has said that it wants to take transparency to the next level, and has committed to making clinical research more accessible and understandable across the pharmaceutical industry.
Weekly digest: what’s happening in open science?
Featuring the release of the AMWA-EMWA-ISMPP position statement on predatory publishing, the hidden disclosures of medical journal editors, the citation advantage of preprints and the launch of the Open Pharma Calendar of Open Access Events
Weekly digest: what’s happening in open science?
Featuring the lack of transparency across clinical trials in French hospitals, the introduction of Registered Reports, the data detective who protects patients and one patient advocate’s experience with the medical publishing process